Morning Market Losers

Gevo GEVO dropped 25.30% to $1.24 after the company priced an offering of 18.53 million common stock units at a public offering price of $1.35 per unit. Avanir Pharmaceuticals AVNR plummeted 17.95% to $3.52 after the company reported that phase II PRIME study of investigation drug AVP-923 did not meet primary efficacy endpoint. The company also reported a wider Q4 loss. Banco Bradesco SA BBDO dropped 11.20% to $13.32. Banco Bradesco's trailing-twelve-month ROA is 1.34%. Tonix Pharmaceuticals Holding TNXP dropped 10.04% to $8.12 after the company announced the enrollment of completers from the BESTFIT trial into a 12-month open-label extension study.